Showing 1 - 20 results of 5,117 for search '(( free ((small decrease) OR (a decrease)) ) OR ( a ((large decrease) OR (marked decrease)) ))', query time: 0.60s Refine Results
  1. 1
  2. 2
  3. 3

    Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc by Lei Wang (6656)

    Published 2025
    “…Background<p>Pralsetinib is a selective RET inhibitor. The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …”
  4. 4
  5. 5

    Dox-inducible expression of HA-MAD1 in colon is sufficient to decrease p53 expression and cause chromosome missegregation. by Sarah E. Copeland (13951506)

    Published 2024
    “…Colors indicate samples from different animals. Large circles show mean of cells from 5 fields of view from a single animal. …”
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Neutralization with additional bevacizumab to serum samples pre- and post-bevacizumab administration. by Masashi Okawa (8951294)

    Published 2024
    “…Serum samples after bevacizumab treatment with an additional 2, 20, or 200 μg/mL of bevacizumab were compared to control samples without bevacizumab, indicating that free VEGF-A121 remained even at high doses of bevacizumab addition. …”
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20